Search research articles
Contact Us
Filters
Showing results (131-140 of 267) with videos related to
Page
of 27
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 21, 2012
Macrophage killing of bacterial and fungal pathogens is not inhibited by intense intracellular accumulation of the lipoglycopeptide antibiotic oritavancin
Beverlie Baquir, Sandrine Lemaire, Françoise Van Bambeke, et al.
JAMA Internal Medicine
|
April 1, 2020
Evaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective Endocarditis: A Narrative Review
Brad Spellberg, Henry F Chambers, Daniel M Musher, et al.
Antimicrobial Agents and Chemotherapy
|
January 20, 2021
Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii
Jiaqi Cheng, Jun Yan, Zeferino Reyna, et al.
Annals of Internal Medicine
|
October 8, 2019
Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board
Brad Spellberg, Travis B Nielsen, David N Gilbert, et al.
Clinical Microbiology Reviews
|
December 16, 2016
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Darren Wong, Travis B Nielsen, Robert A Bonomo, et al.
The New England Journal of Medicine
|
June 20, 2019
Sustainable Discovery and Development of Antibiotics - Is a Nonprofit Approach the Future?
Travis B Nielsen, Eric P Brass, David N Gilbert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 6, 2004
Trends in antimicrobial drug development: implications for the future
Brad Spellberg, John H Powers, Eric P Brass, et al.
Surgery Open Science
|
May 10, 2021
SARS-CoV-2-related outcomes after surgical procedures on SARS-CoV-2-positive patients in a large, urban, safety net medical center
Rachel E Sargent, Stephen F Sener, Rodolfo Amaya, et al.
The Journal of Infectious Diseases
|
April 27, 2010
Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target
Guanpingsheng Luo, Ashraf S Ibrahim, Brad Spellberg, et al.
Journal of Healthcare Leadership
|
April 2, 2026
A Once-in-a-Generation Transformation at an Academic Public Hospital During Federal Funding Uncertainty
Brad Spellberg, Charles E Coffey, Liz Bickley, et al.
Page
of 27
Search research articles
Search
Showing results (131-140 of 267) with videos related to
Sort By:
Page
of 27
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 21, 2012
Macrophage killing of bacterial and fungal pathogens is not inhibited by intense intracellular accumulation of the lipoglycopeptide antibiotic oritavancin
Beverlie Baquir, Sandrine Lemaire, Françoise Van Bambeke, et al.
JAMA Internal Medicine
|
April 1, 2020
Evaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective Endocarditis: A Narrative Review
Brad Spellberg, Henry F Chambers, Daniel M Musher, et al.
Antimicrobial Agents and Chemotherapy
|
January 20, 2021
Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii
Jiaqi Cheng, Jun Yan, Zeferino Reyna, et al.
Annals of Internal Medicine
|
October 8, 2019
Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board
Brad Spellberg, Travis B Nielsen, David N Gilbert, et al.
Clinical Microbiology Reviews
|
December 16, 2016
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Darren Wong, Travis B Nielsen, Robert A Bonomo, et al.
The New England Journal of Medicine
|
June 20, 2019
Sustainable Discovery and Development of Antibiotics - Is a Nonprofit Approach the Future?
Travis B Nielsen, Eric P Brass, David N Gilbert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 6, 2004
Trends in antimicrobial drug development: implications for the future
Brad Spellberg, John H Powers, Eric P Brass, et al.
Surgery Open Science
|
May 10, 2021
SARS-CoV-2-related outcomes after surgical procedures on SARS-CoV-2-positive patients in a large, urban, safety net medical center
Rachel E Sargent, Stephen F Sener, Rodolfo Amaya, et al.
The Journal of Infectious Diseases
|
April 27, 2010
Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target
Guanpingsheng Luo, Ashraf S Ibrahim, Brad Spellberg, et al.
Journal of Healthcare Leadership
|
April 2, 2026
A Once-in-a-Generation Transformation at an Academic Public Hospital During Federal Funding Uncertainty
Brad Spellberg, Charles E Coffey, Liz Bickley, et al.
Page
of 27